Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer

Abstracts: Background: Human epidermal growth factor receptor 2(HER2) status is a crucial predictive factor for prognostic assessment and targeted therapy selection, which may be influenced by intratumor heterogeneity and molecular divergence between the primary site and different metastases. There...

Full description

Bibliographic Details
Main Authors: Xiuwen Guan, Binliang Liu, Yunyun Niu, Xin Dong, Xia Zhu, Chunxiao Li, Lixi Li, Zongbi Yi, Xiaoying Sun, Hongyan Chen, Sijia Lu, Fei Ma
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977619312172